Back to results
US 10,881,626 B2Granted
Controlled release oral pharmaceutical dosage forms comprising MGBG
AssigneePathologica LLC
InventorsJohn McKearn, Jeremy Blitzer
Life of this patent
Estimating the term…
Abstract
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
Claims12
A method of treating inflammation or an inflammatory condition, comprising the administration, to a patient in need thereof, a delayed-release oral pharmaceutical dosage form comprising methylglyoxal bis(guanylhydrazone) (MGBG) and an enteric coating.
Dependencies are inferred from the claim text.